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ABSTRACT
Objective: Levetiracetam (LEV) at lower doses (50 and 100 μg/ml) has demonstrated antioxidant effect as per literature evidence. Hence, the aim of 
current study was to evaluate the action of LEV on wound healing with regard to its antioxidant properties.
Methods: A total of 30 adult rats of both the sexes weighing 150–250 g were randomly divided into five groups of six rats each. Excision and burn 
models were used. The five groups are as follows: Group 1: Normal saline, Group 2: Povidone-iodine, Group 3: Silver sulfadiazine, Group 4: LEV 
50 mg/kg, and Group 5: LEV 100 mg/kg. Group 2 served as a standard control for excision wound model and Group 3 as a standard for burn wound 
model. LEV was given orally and all other drugs were given topically. The rate of wound contracture and period of epithelization were calculated from 
the initial wound size for all rats.
Results: In both the models, the rats treated with standard drug (povidone-iodine/silver sulfadiazine) and LEV showed faster rates of wound 
contraction, period of epithelization, and better antioxidant effect as compared to the control and the difference seen was statistically significant 
(p<0.001). However, the rats treated with povidone-iodine/silver sulfadiazine showed faster rates of wound contraction and period of epithelization 
as compared to the rats treated with LEV and the difference was statistically significant (p<0.05).
Conclusion: The results of the study show that oral application of LEV enhanced the wound strength and accelerated healing of incision and burn 
wounds in rats. Further clinical trials can be done to prove the effect of LEV as an agent for wound healing.
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INTRODUCTION
Wound healing is the process of tissue repair involving the tissue 
response to injury. It is the natural reaction of the body consisting of the 
regeneration of the dermal and epidermal tissue. Several overlapping 
phases such as hemostasis, inflammation, proliferation, and maturation 
play vital roles in the process of wound healing [1]. Following an injury, 
the tissue gets disrupted and it is collagen which is required to repair 
and restore the normal structure and function. Healing process occurs 
immediately after infliction of the wound and takes place in four stages. 
Coagulation is the first phase that occurs to control the extensive blood 
loss due to injury. The next phase is characterized by inflammation 
and debridement of wound, followed by reepithelialization. 
Reepithelialization itself includes various stages such as proliferation, 
migration, and differentiation of squamous epithelial cells of the 
epidermis. Collagen deposition and remodeling in the dermis mark 
the last stage of the healing process [2]. For proper healing, all phases 
should occur accordingly, at a specific duration of time.
There are various factors that interfere with these phases, thus 
hindering the process of wound healing. Healing of the wound can 
be affected by various factors such as depth, size, location, age of the 
patient, nutritional status, and medications [3]. Microbial infection 
along with molecular oxygen and reactive oxygen species (ROS) plays a 
central role in the pathogenesis of wounds. These factors tend to cause 
cytotoxicity and delay wound healing [4]. A continuous generation of 
ROS such as superoxide radical and hydrogen peroxide is the hallmark 
of inflammation. Excess production of these ROS creates an imbalance 
with the protective antioxidant defense mechanisms of the body leading 
to oxidative stress [5].
The second-generation antiepileptic drug levetiracetam (LEV) is a 
new molecule that is clearly differentiated from the conventional 
antiepileptic drug by its pharmacologic properties and mechanism of 
action [6,7]. Although the exact molecular mechanism of action of LEV 
remains uncharacterized, it is known that this drug binds to synaptic 
vesicle protein 2A. By binding to this vesicle, this drug appears to act as 
modulator of synaptic vesicle exocytosis, leading to direct inhibition 
of synaptic neurotransmitter release. Moreover, LEV also has been 
previously demonstrated to protect against oxidative stress-induced 
neurotoxicity in several models of seizures [8,9]. Antioxidative enzymes 
and their isoforms constitute a cellular defense system against oxidative 
stress at the corresponding subcellular positions. At the same time, they 
permit the low concentrations of ROS to equilibrate, serving as signaling 
pathways to regulate the wound healing process [10]. LEV at lower 
doses (50 and 100 µg/ml) prevented pro-oxidative changes, reducing the 
lipid peroxidation, nitrite contents, and catalase activity and increasing 
glutathione (GSH) levels [11]. A search of the literature showed that the 
effect of LEV on wound healing has not been assessed. In view of its known 
antioxidant, the present study is to evaluate the effect of LEV on wound 
healing in rats using excision and burn model in comparison with standard 
drugs such as povidone-iodine and silver sulfadiazine, respectively.
METHODS
The experiments were conducted according to the Committee for 
Prevention of Control and Supervision of Experimental Animals, and 
the Institutional Animal Committee approval was obtained.
Animals
Thirty adult male/female Wistar rats, weighing 150–250 g, were housed 
in polypropylene cages, maintained under the standard condition 
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with temperature (22–24°C), 12 h light/12 h dark cycle, and relative 
air humidity of 40–60%. Rats had continuous access to normocaloric 
standard rat pellet diet and tap water. The animals were acclimatized to 
the laboratory conditions for 1 week before the start of the experiment.
Chemicals/drugs
Stamp, ink, hot air oven, sterile syringes, gloves, forceps, scissors, 
metal cylinder for burn wound, scalpel, feeding needle, LEV, betadine 
ointment, silver sulfadiazine ointment, and normal saline were used.
Experimental design
The animals were divided into five groups of six animals each. Excision 
and burn wound model were used; Group 1: Normal control (0.9% 
saline), Group 2: Standard control (povidone-iodine in excision wound 
model), Group 3: Standard control (Silver sulfadiazine in case of 
burn wound model), Group 4: LEV 50 mg/kg for excision model, and 
Group 5: LEV 50 mg/kg for burn model. Standard drugs were used as a 
topical application and LEV was given orally daily until wound healing 
was complete or for 21 days whichever was earlier. The dose of all 
drugs was chosen based on previous literature [11].
Excision wound model
The excision wounds were created under ketamine anesthesia (50 mg/kg 
body weight), given intramuscularly after working area sterilization. 
The rats were shaved, and skin was cleaned with the cotton swab 
soaked in 70% alcohol. A round skin area of 500 mm² approximately 
was demarcated in diameter, on the dorsal thoracic region 5 cm away 
from the ears as described by Morton and Malone [12]. The entire full 
thickness of the skin from the demarcated area was excised. Wound 
contraction from the initial wound size and the period epithelization 
was calculated on the days 4, 8, 12, and 16.
WordConcentration=




Partial thickness burn wound was inflicted, on overnight-starved 
animals under pentobarbitone (30 mg/kg, i.p.) by pouring hot molten 
wax at 80°C into a metal cylinder of 300 mm² circular openings placed 
on the shaved back of the animal. Treatment started on the day 2 after 
the injury. Wound contraction from the initial wound size and the 
period epithelization was calculated on the days 4, 8, 12, and 16.
Histopathological analysis
Skin biopsy was taken using punch biopsy needle on the day 16 after 
completion of treatment using each model. The biopsied tissue was 
sent for histopathological analysis. Skin specimens from rats of three 
groups (for each model) were collected in 10% buffered formalin, and 
after the usual processing, 5-µm thick sections were cut and stained 
with hematoxylin and eosin. Sections were qualitatively assessed under 
the light microscope and graded with respect to fibroblast proliferation, 
collagen formation, epithelization, and keratinization.
Statistical analysis
One-way analysis of variance along with Tukey’s post hoc analysis were 
used to compare between the groups and a p value of <0.05 was taken 
as significance. Analysis was down using SPSS version 23.0.
RESULTS
In both excision and burn models, the rats in all the groups showed 
adequate healing with wound contraction and epithelialization of the 
wound by the 20th day of the experiment. When the rate of wound 
contraction was assessed, the rats treated with standard drugs and 
LEV showed faster rates of wound contraction as compared to the rats 
treated with normal saline which served as control and the difference 
seen was statistically significant. The rats treated with the test drug, 
i.e., LEV given orally showed the rate of wound contraction that was 
comparable to that seen with the standard drugs until 8th day and there 
was no statistically significant difference. However, the rats treated with 
povidone-iodine and silver sulfadiazine showed faster rates of wound 
contraction as compared to the rats treated with LEV as seen on the 
days 12th and 16th after the wound was inflicted (Tables 1 and 2). The 
period of epithelialization in the standard and test groups was shorter 
as compared to that seen in the control group and the difference was 
statistically significant. The period of epithelialization in the standard 
group was shorter as compared to the test group and the difference 
showed statistical significance (Tables 3 and 4).
Histopathological analysis was performed for both the models as shown 
in Figs. 1 and 2. Both standard and test groups showed better healing 
when compared with control. The control group showed subnormal 
repaired tissue. Epidermis and dermis were not clearly separated. 
Hair follicles and the muscular tissue are also seen in the primitive 
stage in the deeper parts with minimal neovascularization. Superficial 
parts have immature stroma with scanty blood vessels. The standard 
group showed bundles of connective fibers characteristic of collagen 
maturation. Neovascularization has taken place, and the blood vessels 
are clearly seen. More superficial parts of the section show a dense 
population of cells which are closely packed, indicating that the stroma 
is lacking or yet to form. Distinction between dermis and epidermis 
was noted. In the LEV-treated group, there was apparent distinction 
between epidermis and dermis. Dermis has well-developed connective 
Table 1: Effect of LEV on the rate of wound contraction in an excision wound
Groups Drug Wound contraction % in mean±SEM
Day 4 Day 8 Day 12 Day 16
1 Control (saline) 21.91±0.29 43.18±0.52 68.43±0.31 81.83±0.32
2 Povidone-iodine (topical) 31.11±0.57a 52.04±0.64ab 78.30±0.46ab 93.27±0.39ab
3 LEV (oral) 30.17±0.39a 51.07±0.36a 76.58±0.55a 91.67±0.31a
Values are expressed as mean±S.E.M. Statistical analysis was done using one-way ANOVA followed by Tukey’s post hoc test. ap<0.01 versus control, bp<0.05 versus LEV. 
ANOVA: Analysis of variance, SEM: Standard error of the mean, LEV: Levetiracetam
Table 2: Effect of LEV on the rate of wound contraction in a burn wound
Groups Drug Wound contraction % in mean±SEM
Day 4 Day 8 Day 12 Day 16
1 Control (saline) 21.91±0.29 43.18±0.52 68.43±0.31 81.83±0.32
2 Silver sulfadiazine (topical) 30.11±0.57a 49.04±0.64ab 82.30±0.46ab 96.27±0.39ab
3 LEV (oral) 29.17±0.39a 48.57±0.36a 81.58±0.55a 90.67±0.31a
Values are expressed as mean±S.E.M. Statistical analysis was done using one-way ANOVA followed by Tukey’s post hoc test. ap<0.05 versus control, bp<0.05 versus LEV. 
ANOVA: Analysis of variance, SEM: Standard error of the mean, LEV: Levetiracetam
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tissue. Cell is clearly distinct with matured collagenous connective 
tissue. Blood vessels are well developed, and the glands and muscular 
tissues are very clearly seen. Healing is comparable to the standard 
treatment group.
DISCUSSION
This study was undertaken to evaluate the effect of oral LEV on healing 
of excision and burn wounds in rats. Two models were used to assess 
wound healing properties of LEV in excision and burn wound. Although 
all two models are models of acute wound, burn wound differs in many 
aspects with other wounds. Hence, burn wound model was included. 
Further, these wounds heal by different models (healing by primary 
or secondary intention) and various aspects of wound healing can be 
studied only in certain models. Hence, different models were used in 
our studies [13]. Rat was used as a model due to the ease of availability 
and abundant literature available for it. Male rats were used to avoid the 
confounding effect of estrogen on wound healing [14]. Size of wound 
is an important predictor of wound healing. The results of the study 
show that oral application of LEV enhanced the wound strength and 
accelerated healing of excision and burn wounds in rats.
LEV is a pyrrolidine, the rechemically pure S-enantiomer of -ethyl-
2-oxo-1pyrrolidineacetamide. LEV exhibits a novel pharmacological 
profile in so far as it inhibits partial and secondary generalized tonic-
clonic seizures in the kindling model. The mechanism of action of LEV is 
uncertain. No evidence for its action on the voltage-gated Na+ channel 
or either gamma-aminobutyric acid or glutamate-mediated synaptic 
transmission has emerged. The correlation between the binding affinity 
of LEV analogs and their potency toward audiogenic seizures suggest 
that a synaptic vesicle protein, SV2A, mediates an anticonvulsant 
effect of LEV. LEV is rapidly and almost completely absorbed after oral 
administration. 95% of the drug is excreted in urine. 65% excreted 
unchanged and 24% of the drug metabolized by hydrolysis of acetamide 
group [7].
Epithelialization is the process of restoring the stratified epithelium 
following injury. This involves migration and proliferation of 
epithelial cells. The migration is further facilitated by degradation 
of extracellular matrix in the way of keratinocyte progression by 
different metalloproteinases. When a layer of epithelial the cell is 
established, migration and proliferation stop and differentiation of 
the cell starts to provide stratified epithelium. Wound contraction, 
manifesting as shrinkage of wound area, starts around 4th-day post-
wounding and is completed by 16th day [15]. In the present study, 
LEV significantly accelerated wound healing in excision wound and 
showed better wound contraction than normal saline (control) 
treatment. In burn wound model, LEV-treated group enhanced 
epithelialization as well as the rate of wound contraction. Burn 
wound is usually associated with ischemia followed by restoration 
of blood flow.
Antioxidants are believed to quench free radicals. Free radicals are 
molecules with singlet unpaired electron which makes them highly 
reactive. Oxidative free radicals generated by metabolic reactions 
create a chain reaction leading to membrane lipid peroxidation and 
DNA damage [10]. Antioxidants lower inflammation markers and 
facilitate wound healing by promoting fibroblasts migration [10]. LEV 
has rich antioxidant property. Mechanism of LEV involves antioxidant 
properties. Moreover, LEV also has been previously demonstrated 
to protect against oxidative stress-induced neurotoxicity in several 
models of seizures [8,9]. LEV and clonazepam, mainly at lower doses 
(50 and 100 µg/ml), and similarly to Vitamin C, prevented pro-oxidative 
changes, reducing the lipid peroxidation, nitrite contrite contents, and 
catalase activity and increasing GSH levels [11].
Table 3: Effect of LEV on the period of epithelialization in an 
excision wound
Group (n=6) Drug Period of epithelialization (days) 
mean±S.E.M
Control Paraffin wax 18.67±0.21
Standard Povidone-iodine 15.83±0.31ab
Test LEV 16.83±0.17a
Values are expressed as mean±S.E.M. Statistical analysis was done using 
one-way ANOVA followed by Tukey’s post hoc test. ap<0.001 versus control, 
bp<0.05 versus LEV. ANOVA: Analysis of variance, SEM: Standard error of the 
mean, LEV: Levetiracetam
Table 4: Effect of LEV on the period of epithelialization in a burn 
wound
Group (n=6) Drug Period of epithelialization (days) 
mean±S.E.M
Control Paraffin wax 18.83±0.17
Standard Silver sulfadiazine 15.50±0.22ab
Test LEV 16.50±0.22a
Values are expressed as mean±S.E.M. Statistical analysis was done using 
one-way ANOVA followed by Tukey’s post hoc test. ap<0.001 versus control, 
bp<0.05 versus LEV. ANOVA: Analysis of variance, SEM: Standard error of the 
mean, LEV: Levetiracetam
Fig. 1: Excision wound model histopathological analysis. 
(a) Normal control, (b) Standard povidone-iodine, 





Fig. 2: Burn wound model histopathological analysis. (a) Normal 
control, (b) Standard silver sulfasalazine, (c) Levetiracetam (LEV) 
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CONCLUSION
LEV demonstrated to have an antioxidant effect can accelerate wound 
healing. The rate of wound contraction with oral LEV was as fast as 
standard topical treatment for burn wound and excision wound. Hence, 
proper clinical trials can be designed, and various wound models can be 
used to evaluate the effect of LEV on healing.
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